Anatomic Pathology
FDA: Device Delivers Non-invasive Therapy and Supports Care at Home White Oak, Md., Feb. 12, 2026 (GLOBE NEWSWIRE) -- The U.S. Food and Drug Administration has approved a first-of-its-kind device for the treatment of adult patients with...
Seattle, WA – February 3, 2026 – RevealDx, a leader in AI tools for the characterization of lung nodules, announced FDA clearance of RevealAI-Lung. The company had previously announced MDR Certification in November of 2025. The RevealDx...
February 2, 2026 at 10:00 a.m. EET. Aiforia Technologies Plc today announced the launch of a new clinical AI solution for gastric cancer diagnostics. This solution is CE-IVD marked under the IVDR. Aiforia® Gastric Cancer AI application is...
From CNN: The five-year cancer survival rate in the US has reached 70% for the first time, according to an American Cancer Society report released yesterday. The figure, based on diagnoses from 2015 to 2021, is up from 49% in...
OREM, UT, UNITED STATES, December 30, 2025 /EINPresswire.com/ -- Techcyte, a leading provider of AI-powered digital diagnostics for anatomic and clinical pathology, today announced the publication of a peer-reviewed study in Diagnostics...
OREM, UT, UNITED STATES, December 26, 2025 /EINPresswire.com/ -- Techcyte, a leading provider of AI-powered digital diagnostics for anatomic and clinical pathology, today reaffirmed its long-standing SOC 2 Type II compliance, which the...
